Skip to main content

Micro mobility Providing First and Last Mile Connectivity for Commuters

Technological innovation in the transportation industry encompasses a comprehensive range of mobility methods delivering a broad range of products to the industry. Modern day's consumer is well-connected and well-informed, and as a result, this is leading the major operating players to research, develop, and technologically evolve continuously to safeguard their position in the ecosystem. Transportation system regulations are primarily designed around demographic needs based on the government policy framework. Some of the essential criteria which are taken into consideration while creating a policy regulation for a specific region are- the socio-economic conditions, commuter lifestyle, degree of technology acceptance, demographic terms, infrastructure availability, and global economic conditions. 

Mobility as a service (MaaS) providers have established a strong foundation for the development shared mobility ecosystem, which has the potential to ensure high resource utilization rate unlike the conventional method of personal vehicle ownership model. The foundation also leads to an essential fact that there are gaps in MaaS and end-to-end connectivity; and here, micro mobility performs as a bridge between shared services and their end-to-end connectivity. Micro mobility service is the efficient use of light, compact, and swift modes of commute majorly powered by human or electric. The micro mobility as a service came into existence in China, driven by Mobike – a bicycle-based ride shares service providers.

For the Report Sample, Click Here:https://bisresearch.com/requestsample?id=745&type=download

The micro mobility technologies have currently witnessed a sudden upsurge due to many factors, some of which are detailed below:

  • The reduction in cost of mode procurement
  • Growth in technical capability and advance design skills which enabled development of efficient products which could contribute to conservation environment.

Micro mobility modes offer large degree of flexibility of driving on roads, footpaths or dedicated tracks built along with the road network in a city. The road network in the developed nations constitutes of a planned layout with dedicated cycle tracks (that can be used for similar types of vehicles) and footpaths. However, the usage of various modes on different locations is subject to the design and application of each mode. Commercial micro mobility market majorly utilizes road network as it accounts for faster moving vehicles such as motorcycles, mopeds, e-bikes, e-mopeds, and micro electric cars, among others.

Due to certain advancements in technology, the overall cost of the micro-mobility modes such as e-scooters, e-bikes, bicycles, and e-mopeds dropped drastically during the past five-year period between 2013-2018. The option of end-to-end connectivity via these low-cost modes is a lucrative option for the service provider as well as the consumer. These factors reduce the initial cost of investment for the company and enable them to offer a low-cost travel mode in the form of micro-mobility to the end-users. The mobility ecosystem has witnessed the proliferation of electric vehicles and personal portable devices extensively in shared mobility services.

Read Report Overview: https://bisresearch.com/industry-report/micro-mobility-market.html


Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Lung Cancer Genomic Testing Market Industry Structure, Development, Demographics, Demands, Main Players, Innovative Technologies, and Opportunities Till 2031

  The shift of healthcare systems toward precision diagnostic and precision medicine will drive the adoption of lung cancer genomic testing facilitating informed treatment decision making and improving healthcare outcomes. Increasing recommendations by the international oncology societies for the use of genomic testing for lung cancer diagnosis provides major opportunities in the global lung cancer genomic testing market. The  lung cancer genomic testing medicine market  was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031. The growth in the global lung cancer genomic testing market is expected to be driven by increasing awareness and adoption of the lung cancer genomic testing market, recent launches of novel lung cancer genomic testing, and the expanding research in the field of lung cancer with an emphasis on pharmacogenomics and development of companion diagnostics. Im...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more